1. Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization 
Ivana N.M. Micallef, Shirshendu Sinha, Dennis A. Gastineau, Robert Wolf, David J. Inwards, Morie A. Gertz, Suzanne R. Hayman, William J. Hogan, Patrick B. Johnston, Martha Q. Lacy, Stephen M. Ansell, Francis Buadi, David Dingli, Angela Dispenzieri, Mark R. Litzow, Luis F. Porrata, Jeffrey L. Winters, Shaji Kumar 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 1, Pages (January 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) and (B) Flow diagrams of plerixafor risk-adapted algorithms.
Biology of Blood and Marrow Transplantation  , 87-93DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
(A) Kaplan-Meier cumulative incidence plot of percentage of patients achieving CD34 stem cell yield of 2 × 106 CD34/kg based on number of days. (B) Kaplan-Meier cumulative incidence plot of percentage of patients achieving CD34 stem cell yield of 4 × 106 CD34/kg based on number of days.
Biology of Blood and Marrow Transplantation  , 87-93DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions